Skip to main content

Compound Immobilization and Drug-Affinity Chromatography

  • Protocol
  • First Online:
Chemical Proteomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 803))

Abstract

Bioactive small molecules act through modulating a yet unpredictable number of targets. It is therefore of critical importance to define the cellular target proteins of a compound as an entry point to understanding its mechanism of action. Often, this can be achieved in a direct fashion by chemical proteomics. As with any affinity chromatography, immobilization of the bait to a solid support is one of the earliest and most crucial steps in the process. Interfering with structural features that are important for identification of a target protein will be detrimental to binding affinity. Also, many molecules are sensitive to heat or to certain chemicals, such as acid or base, and might be destroyed during the process of immobilization, which therefore needs to be not only efficient, but also mild. The subsequent affinity chromatography step needs to preserve molecular and conformational integrity of both bait compound and proteins in order to result in the desired specific enrichment while ensuring a high level of compatibility with downstream analysis by mass spectrometry. Thus, the right choice of detergent, buffer, and protease inhibitors is also essential. This chapter describes a widely applicable procedure for the immobilization of small molecule drugs and for drug-affinity chromatography with subsequent protein identification by mass spectrometry.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Oda, Y., Owa, T., Sato, T., Boucher, B., Daniels, S., Yamanaka, H., Shinohara, Y., Yokoi, A., Kuromitsu, J., and Nagasu, T. (2003) Quantitative chemical proteomics for identifying candidate drug targets, Anal Chem 75, 2159–2165.

    Article  PubMed  CAS  Google Scholar 

  2. Rix, U., and Superti-Furga, G. (2009) Target profiling of small molecules by chemical proteomics, Nat Chem Biol 5, 616–624.

    Article  PubMed  CAS  Google Scholar 

  3. Han, S.-Y., and Kim, Y.-A. (2004) Recent development of peptide coupling reagents in organic synthesis, Tetrahedron 60, 2447–2467.

    Article  CAS  Google Scholar 

  4. Anderson, G. W., Zimmerman, J. E., and Callahan, F. M. (1963) N-Hydroxysuccinimide esters in peptide synthesis, J. Am. Chem. Soc. 85, 3039.

    Article  CAS  Google Scholar 

  5. Neises, B., and Steglich, W. (1978) Simple method for the esterification of carboxylic acids, Angew. Chem. Int. Ed. Engl. 17, 522–524.

    Article  Google Scholar 

  6. Kocienski, P. J. (2005) Protecting Groups, 3rd ed., Thieme, Stuttgart.

    Google Scholar 

  7. Rix, U., Hantschel, O., Durnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., Kocher, T., and Superti-Furga, G. (2007) Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets, Blood 110, 4055–4063.

    Article  PubMed  CAS  Google Scholar 

  8. Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A., Das, J., Doweyko, A. M., Fairchild, C., Hunt, J. T., Inigo, I., Johnston, K., Kamath, A., Kan, D., Klei, H., Marathe, P., Pang, S., Peterson, R., Pitt, S., Schieven, G. L., Schmidt, R. J., Tokarski, J., Wen, M. L., Wityak, J., and Borzilleri, R. M. (2004) Discovery of N-(2-chloro-6-methyl-  phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4-  ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays, J Med Chem 47, 6658–6661.

    Article  PubMed  CAS  Google Scholar 

  9. Kneidinger, M., Schmidt, U., Rix, U., Gleixner, K. V., Vales, A., Baumgartner, C., Lupinek, C., Weghofer, M., Bennett, K. L., Herrmann, H., Schebesta, A., Thomas, W. R., Vrtala, S., Valenta, R., Lee, F. Y., Ellmeier, W., Superti-Furga, G., and Valent, P. (2008) The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils, Blood 111, 3097–3107.

    Article  PubMed  CAS  Google Scholar 

  10. Tokarski, J. S., Newitt, J. A., Chang, C. Y., Cheng, J. D., Wittekind, M., Kiefer, S. E., Kish, K., Lee, F. Y., Borzillerri, R., Lombardo, L. J., Xie, D., Zhang, Y., and Klei, H. E. (2006) The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants, Cancer Res 66, 5790–5797.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Austrian Federal Ministry for Science and Research (BMWF) under the GEN-AU program (GZ BMWF-70.081/0018-II/1a/2008) and the Austrian Academy of Sciences (ÖAW).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giulio Superti-Furga .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Rix, U., Gridling, M., Superti-Furga, G. (2012). Compound Immobilization and Drug-Affinity Chromatography. In: Drewes, G., Bantscheff, M. (eds) Chemical Proteomics. Methods in Molecular Biology, vol 803. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-364-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-364-6_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-363-9

  • Online ISBN: 978-1-61779-364-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics